SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000920465-17-000070
Filing Date
2017-10-26
Accepted
2017-10-26 17:16:04
Documents
34
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ljpc-2017q3_.htm 10-Q 405756
2 EXHIBIT 31.1 exhibit311fy2017q3.htm EX-31.1 14736
3 EXHIBIT 31.2 exhibit312fy2017q3.htm EX-31.2 14671
4 EXHIBIT 32.1 exhibit321fy2017q3.htm EX-32.1 12463
  Complete submission text file 0000920465-17-000070.txt   1866283

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ljpc-20170930.xml EX-101.INS 291528
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ljpc-20170930.xsd EX-101.SCH 14095
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ljpc-20170930_cal.xml EX-101.CAL 28927
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ljpc-20170930_def.xml EX-101.DEF 62474
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ljpc-20170930_lab.xml EX-101.LAB 224707
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ljpc-20170930_pre.xml EX-101.PRE 128395
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36282 | Film No.: 171157079
SIC: 2836 Biological Products, (No Diagnostic Substances)